Immunization, HepB3 in Marshall Islands
Marshall Islands: Immunization, HepB3 was 89.0% in 2024. ▲ Rising
Immunization, HepB3 in Marshall Islands, 1989–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
Marshall Islands recorded 89.0% for immunization, hepb3 in 2024.
That represents a change of up 12.7% over ten years.
Over the whole period, immunization, hepb3 in Marshall Islands peaked at 99.0% in 2009 and was at its lowest, 3.0%, in 1989.
Marshall Islands ranks 102nd of 188 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 36 years of available data.
Immunization, HepB3 in Marshall Islands, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1989 | 3.0% | — |
| 1990 | 10.0% | +233.3% |
| 1991 | 17.0% | +70.0% |
| 1992 | 24.0% | +41.2% |
| 1993 | 17.0% | -29.2% |
| 1994 | 46.0% | +170.6% |
| 1995 | 47.0% | +2.2% |
| 1996 | 68.0% | +44.7% |
| 1997 | 70.0% | +2.9% |
| 1998 | 80.0% | +14.3% |
| 1999 | 80.0% | +0.0% |
| 2000 | 38.0% | -52.5% |
| 2001 | 76.0% | +100.0% |
| 2002 | 80.0% | +5.3% |
| 2003 | 74.0% | -7.5% |
| 2004 | 72.0% | -2.7% |
| 2005 | 89.0% | +23.6% |
| 2006 | 97.0% | +9.0% |
| 2007 | 93.0% | -4.1% |
| 2008 | 97.0% | +4.3% |
| 2009 | 99.0% | +2.1% |
| 2010 | 97.0% | -2.0% |
| 2011 | 89.0% | -8.2% |
| 2012 | 80.0% | -10.1% |
| 2013 | 80.0% | +0.0% |
| 2014 | 79.0% | -1.2% |
| 2015 | 85.0% | +7.6% |
| 2016 | 73.0% | -14.1% |
| 2017 | 82.0% | +12.3% |
| 2018 | 84.0% | +2.4% |
| 2019 | 82.0% | -2.4% |
| 2020 | 86.0% | +4.9% |
| 2021 | 89.0% | +3.5% |
| 2022 | 87.0% | -2.2% |
| 2023 | 89.0% | +2.3% |
| 2024 | 89.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.0% | 3.0% | 3.0% | 1 |
| 1990s | 45.9% | 10.0% | 80.0% | 10 |
| 2000s | 81.5% | 38.0% | 99.0% | 10 |
| 2010s | 83.1% | 73.0% | 97.0% | 10 |
| 2020s | 88.0% | 86.0% | 89.0% | 5 |
Countries ranked near Marshall Islands
- 102 Burundi 89.0% compare
- 102 Colombia 89.0% compare
- 102 Netherlands 89.0% compare
- 102 New Zealand 89.0% compare
- 102 Nicaragua 89.0% compare
More health data for Marshall Islands
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Population, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population, male, annual growth rate -3.51 % change on previous year (2025)
- Population, male, per capita 0.5116 units per person (2025)
- Deaths in armed conflicts based on where they occurred 0 deaths (2026)
- Deaths in armed conflicts by region 0 deaths (2026)
- Age population, age 19, female, interpolated 422 (2025)
Frequently asked questions
- What is immunization, hepb3 in Marshall Islands?
- Immunization, hepb3 in Marshall Islands was 89.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Marshall Islands?
- The highest recorded value was 99.0% in 2009.
- What is the lowest immunization, hepb3 recorded in Marshall Islands?
- The lowest recorded value was 3.0% in 1989.
- How does Marshall Islands rank for immunization, hepb3?
- Marshall Islands ranks 102nd out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in Marshall Islands?
- Over the last ten years it is up 12.7%. The long-run trend across the full record is rising.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 36 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.